Tag: Reverse Payments

As complex as reverse-payment antitrust lawsuits can be, the one being litigated against generic drug maker Ranbaxy over its settlement with Cephalon can be...

Last June, the U.S. Supreme Court finally tackled Reverse Payments. In Actavis, they leaned away from many lower court decisions and acknowledged that reverse...

This Autumn 2009 issue marks several anniversaries; it is the tenth volume of CPI, the end of our fifth year, and the last issue...

Kyle Musgrove, Richard Ripley, Sep 30, 2013 Three months now have passed following the Supreme Court's decision inFTC v. Actavis, 133 S. Ct. 2223 (2013),...

Michael Kades, Nov 01, 2009 Arguably, the most important debate in antitrust jurisprudence involves pay-for-delay patent settlements in which the brand company pays the generic...